Georgina Long, PhD

Melanoma Institute Australia, Faculty of Medicine and Health, The University of Sydney, and Mater and Royal North Shore Hospitals, Australia

Poster(s):

• (P 433) PHASE I DOSE ESCALATION TRIAL OF STX-001, AN LNP SELF-REPLICATING MRNA EXPRESSING IL-12, IN PATIENTS WITH REFRACTORY TUMORS INCLUDING SARCOMAS